Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Power List / 2017 / Pharma Pioneers / Gerard Hopfgartner

Gérard Hopfgartner

Professor in Analytical Sciences and Mass Spectrometry, Department of Analytical and Inorganic Chemistry, University of Geneva, Switzerland.

  • Profile

Meet Gérard Hopfgartner

Why analytical science?
Being a chemist by education, I was motivated by the use of technology (in particular mass spectrometry) to collect scientific knowledge that benefits people and society

Proudest career moment
My team’s paradigm shift in the early 1990s in bioanalysis – moving from liquid chromatography with classical detectors such as UV or fluorescence, to liquid chromatography with tandem mass spectrometry detection to support drug discovery and development.

Key trends in pharmaceutical analysis
New challenges in drug development and personalized medicine considering efficacy and toxicology of drugs and biologics call for novel high-throughput automated multi-analyte bioanalytical workflows. Simplified multidimensional mass spectrometry approaches integrating ion mobility and miniaturized sample preparation should open new possibilities for large-scale real-time analysis.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.